We analyzed the overall survival of patients with tumors harboring BRCA2, RAD51C or combinations of BRCA2 + RAD51C mutations using the breast cancer genome datasets available at cBioportal.org39,40. This evidence concerns the gene BRCA2 and breast cancer.